Cargando…

Drug-induced skin reactions: a 2-year study

BACKGROUND: The aim of this study was to analyze the clinical characteristics of patients with adverse cutaneous drug reactions, which occur when a medicinal product results in cutaneous morbidity. METHODS: The study included 308 patients who were diagnosed as having an adverse cutaneous drug reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Farshchian, Mahmood, Ansar, Akram, Zamanian, Abbas, Rahmatpour-Rokni, Ghasem, Kimyai-Asadi, Arash, Farshchian, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330003/
https://www.ncbi.nlm.nih.gov/pubmed/25709487
http://dx.doi.org/10.2147/CCID.S75849
_version_ 1782357521956077568
author Farshchian, Mahmood
Ansar, Akram
Zamanian, Abbas
Rahmatpour-Rokni, Ghasem
Kimyai-Asadi, Arash
Farshchian, Mehdi
author_facet Farshchian, Mahmood
Ansar, Akram
Zamanian, Abbas
Rahmatpour-Rokni, Ghasem
Kimyai-Asadi, Arash
Farshchian, Mehdi
author_sort Farshchian, Mahmood
collection PubMed
description BACKGROUND: The aim of this study was to analyze the clinical characteristics of patients with adverse cutaneous drug reactions, which occur when a medicinal product results in cutaneous morbidity. METHODS: The study included 308 patients who were diagnosed as having an adverse cutaneous drug reaction during the study period (2007–2009). In 84 cases, histopathologic examination of skin biopsies were also performed. RESULTS: Patients with drug reactions were found to be more commonly female (63%) than male (37%). Beta-lactam antibiotics were found to be the most frequent cause of adverse cutaneous drug reactions (42.7%), followed by non-steroidal anti-inflammatory drugs (16.5%). Acute urticaria was the most common clinical presentation (59.2%) followed by fixed drug eruptions (18.5%), and maculopapular eruptions (14.9%). CONCLUSION: Adverse cutaneous drug reactions in our study population were mainly induced by beta-lactam antibiotics and non-steroidal anti-inflammatory drugs. The most common forms of cutaneous adverse drug reactions were found to be acute urticaria, fixed drug eruptions, and maculopapular rashes.
format Online
Article
Text
id pubmed-4330003
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43300032015-02-23 Drug-induced skin reactions: a 2-year study Farshchian, Mahmood Ansar, Akram Zamanian, Abbas Rahmatpour-Rokni, Ghasem Kimyai-Asadi, Arash Farshchian, Mehdi Clin Cosmet Investig Dermatol Original Research BACKGROUND: The aim of this study was to analyze the clinical characteristics of patients with adverse cutaneous drug reactions, which occur when a medicinal product results in cutaneous morbidity. METHODS: The study included 308 patients who were diagnosed as having an adverse cutaneous drug reaction during the study period (2007–2009). In 84 cases, histopathologic examination of skin biopsies were also performed. RESULTS: Patients with drug reactions were found to be more commonly female (63%) than male (37%). Beta-lactam antibiotics were found to be the most frequent cause of adverse cutaneous drug reactions (42.7%), followed by non-steroidal anti-inflammatory drugs (16.5%). Acute urticaria was the most common clinical presentation (59.2%) followed by fixed drug eruptions (18.5%), and maculopapular eruptions (14.9%). CONCLUSION: Adverse cutaneous drug reactions in our study population were mainly induced by beta-lactam antibiotics and non-steroidal anti-inflammatory drugs. The most common forms of cutaneous adverse drug reactions were found to be acute urticaria, fixed drug eruptions, and maculopapular rashes. Dove Medical Press 2015-02-09 /pmc/articles/PMC4330003/ /pubmed/25709487 http://dx.doi.org/10.2147/CCID.S75849 Text en © 2015 Farshchian et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Farshchian, Mahmood
Ansar, Akram
Zamanian, Abbas
Rahmatpour-Rokni, Ghasem
Kimyai-Asadi, Arash
Farshchian, Mehdi
Drug-induced skin reactions: a 2-year study
title Drug-induced skin reactions: a 2-year study
title_full Drug-induced skin reactions: a 2-year study
title_fullStr Drug-induced skin reactions: a 2-year study
title_full_unstemmed Drug-induced skin reactions: a 2-year study
title_short Drug-induced skin reactions: a 2-year study
title_sort drug-induced skin reactions: a 2-year study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330003/
https://www.ncbi.nlm.nih.gov/pubmed/25709487
http://dx.doi.org/10.2147/CCID.S75849
work_keys_str_mv AT farshchianmahmood druginducedskinreactionsa2yearstudy
AT ansarakram druginducedskinreactionsa2yearstudy
AT zamanianabbas druginducedskinreactionsa2yearstudy
AT rahmatpourroknighasem druginducedskinreactionsa2yearstudy
AT kimyaiasadiarash druginducedskinreactionsa2yearstudy
AT farshchianmehdi druginducedskinreactionsa2yearstudy